The 3 most recent market catalysts affecting $ZEAL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 13, 2026
Corporate Catalyst
Bullish
Impact 85
Zealand Pharma Receives EU Marketing Authorization for Zeydovio (glepaglutide)
Zealand Pharma has secured EU marketing authorization for Zeydovio, a long-acting GLP-2 analog for short bowel syndrome. This is a major positive catalyst as it's the first signifi…
Nov 4, 2026
Corporate Catalyst
Bullish
Impact 75
ZEAL Network Reports 22% Revenue Growth for First Nine Months of 2026
ZEAL Network SE announced a 22% year-on-year revenue increase for the first nine months of 2026, reaching €198.8 million, and a 9% rise in EBITDA. This growth was fueled by its cor…
Oct 13, 2026
Corporate Catalyst
Bullish
Impact 95
'Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion' - Bloomberg
Zealand Pharma has announced a deal with Generate that could be worth up to $1.2 billion. This is a highly significant event for the company, as it represents a substantial influx …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.